EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary Syndrome

Lulu Geng iD, Xin Yang iD, Jiani Sun, Ximing Ran, Dan Zhou, Mingming Ye, Li Wen, Ruirui Wang iD, Miaoxin Chen iD

Advanced Science · 2025-05 · 12 (20)

DOI: 10.1002/advs.202412558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.04.2025. Verfasst von Lulu Geng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Assisted Reproduction, Shanghai Key Laboratory of Maternal-Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic O…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Gastrointestinal Microbiome, Inulin, Ovary. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Talent reservoir program of Shanghai First Maternity and Infant Hospital, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of metabolic disorder associated with polycystic ovary syndrome (PCOS) has been suggested as an effective approach to improve PCOS which is highly involved with gut microbiota, while the underlying mechanism is unclear. Here, we investigated the role of inulin, a gut microbiota regulator, in the alleviation of PCOS. Our findings showed that inulin treatment significantly improved hyperandrogenism and glucolipid metabolism in both PCOS cohort and mice. Consistent with the cohort, inulin increased the abundance of microbial co‐abundance group (CAG) 12 in PCOS mice, including Bifidobacterium species and other short‐chain fatty acids (SCFAs)‐producers. We further verified the enhancement of SCFAs biosynthesis capacity and fecal SCFAs content by inulin. Moreover, inulin decreased lipopolysaccharide‐binding protein (LBP) and ameliorated ovarian inflammation in PCOS mice, whereas intraperitoneal lipopolysaccharide (LPS) administration reversed the protective effects of inulin. Furthermore, fecal microbiota transplantation (FMT) from inulin‐treated patients with PCOS enhanced insulin sensitivity, improved lipid accumulation and thermogenesis, reduced hyperandrogenism and ovarian inflammatory response in antibiotic‐treated mice. Collectively, these findings revealed that gut microbiota mediates the beneficial effects of inulin on metabolic disorder and ovarian dysfunction in PCOS. Therefore, modulating gut microbiota represents a promising therapeutic strategy for PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeGastrointestinal MicrobiomeInulinOvaryFemaleAnimalsMiceFecal Microbiota TransplantationHumansDisease Models, AnimalFatty Acids, Volatile

Stichwörter der Autor:innen

fecal microbiota transplantationgut microbiotainulinpolycystic ovary syndromeshort‐chain fatty acids

Substanzen

InulinFatty Acids, Volatile

Autor:innen und Institutionen

  • Centre for Assisted Reproduction, Shanghai Key Laboratory of Maternal-Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medic…
  • Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Section of Endocrinology, Internal Medicine, School of Medicine, Yale University, New Haven, CT, 06520, USA.
  • Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

ORCID-Profile: Lulu Geng, Xin Yang, Ruirui Wang, Miaoxin Chen

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • Talent reservoir program of Shanghai First Maternity and Infant Hospital
  • National Natural Science Foundation of China
  • Shanghai Municipal Hospital Development Center
  • Shanghai Collaborative Innovation Center for Chronic Disease Prevention and Health Services

Zitieren

APA

Geng, L., Yang, X., Sun, J., Ran, X., Zhou, D., Ye, M., Wen, L., Wang, R., & Chen, M. (2025). Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary Syndrome. Advanced Science, 12(20). https://doi.org/10.1002/advs.202412558

Vancouver

Geng L, Yang X, Sun J, Ran X, Zhou D, Ye M, et al. Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary Syndrome. Advanced Science. 2025;12(20). doi:10.1002/advs.202412558

BibTeX
@article{Geng2025,
  author = {Geng, Lulu and Yang, Xin and Sun, Jiani and Ran, Ximing and Zhou, Dan and Ye, Mingming and Wen, Li and Wang, Ruirui and Chen, Miaoxin},
  title = {Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary Syndrome},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {20},
  doi = {10.1002/advs.202412558}
}
Kostenlos starten →